Human leukocyte antigens in forms of leprosy among Japanese patients

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 68, Issue 1, 2000, Pages 49-56

  Joko, Satoru ^b   Numaga, Jiro ^b   Kawashima, Hidetoshi ^b   Namisato, Masako ^a   Maeda, Hiroo ^b  

^a National Leprosarium Tama Zenshoen   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; BORDERLINE LEPROSY; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE FREQUENCY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; JAPAN; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; TUBERCULOID LEPROSY;

CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA, BACTERIAL; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; LEPROSY; MYCOBACTERIUM LEPRAE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0034070396     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ABEL, L., SANCHETS, O. F., OBERTI, J., THUC, V. N., HOA, L. V., LAP, V. D., SKAMENE, E., LAGRANGE, P. H. and SCHURR, E. Susceptibility to leprosy is linked to the human NRAMP1 gene. J. Infect. Dis. 177 (1998) 133-145.
2. AKIYAMA, K., YOSHII, T. and ISHIYAMA, I. [Investigation of the medium composition for PCR-SSCP analysis of the HLA-DQA gene region.] Jpn. J. Electroph. 37 (1993) 41-44.
3. BALE, U. M., MEHTA, M. M., CONTRACTOR, N. M., BHATIA, H. M. and KOTICHA, K. K. HLA antigens in leprosy patients. Tissue Antigens 20 (1982) 141-143.
4. CHAKRAVARRTI, M. R. and VOGEL, F. A twin study on leprosy. In: Topics in Human Genetics, Vol. 1. Becker, P. E., et al., eds. Stuttgart: Thieme Verlag, 1973, pp. 1-23.
5. DESSOUKEY, M. W., EL-SHIEMY, S. and SALLAM, T. HLA and leprosy segregation and linkage study. Int. J. Dermatol. 35 (1996) 257-264.
6. DORMAN, S. E. and HOLLAND, S. M. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101 (1998) 2364-2369.
7. GORODEZKY, C., FLORES, J., AREVALO, N., CASTRO, L., SILVA, A. and RODRIGUEZ, O. Tuberculoid leprosy in Mexicans is associated with HLA-DR3. Lepr. Rev. 58 (1997) 401-406.
8. GOTO, M., SUZUK, M., KITAJIMA, S. and IMAIZUMI, M. [Changes and present status of a Japanese National Leprosarium-analysis of smear positive rate and relapse in Hosizuka-Keiaien between 1972-1991.] Jpn. J. Lepr. 62 (1993) 1-12.
9. HACKAM, D. J., ROTSEIN, O. D., ZHANG, W., GRUENHEID, S., GROS, P. and GRINSTEIN, S. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Exp. Med. 188 (1998) 351-364.
10. ISLAM, S. M. M., NUMAGA, J., FUJINO, Y., HIRATA, R., MATUKI, K., MAEDA, H. and MASUDA, K. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest. Ophthalmol. Vis. Sci. 35 (1994) 3890-3896.
11. IZUMI, S., SUGIYAMA, K., MATSUMOTO, Y. and OHKAWA, S. Analysis of the immunogenetic background of Japanese leprosy patients by the HLA system. Vox Sang. 42 (1982) 243-247.
12. JOKO, S., NUMAGA, J., FUJINO, Y, MASUDA, K., HIRATA, R. and MAEDA, H. [HLA-DR2 alleles and uveitis in leprosy.] Jpn. J. Lepr. 64 (1995) 112-118.
13. KIM, S. J., CHOI, I. H., DAHLHLRG, S., NISPEROS, B., KIM, J. D. and HANSEN, J. A. HLA and leprosy in Koreans. Tissue Antigens 29 (1987) 146-153.
14. KIMURA, A. and SASAZUKI, T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: HLA 1991. Tsuji, K., Aizawa, M. and Sasazuki, T., eds. Oxford: Oxford University Press, 1992, pp. 397-419.
15. LEVIS, W. R., SCHUMAN, J. S., FRIEDMAN, S. M. and NEWFIELD, S. A. An epidemiologic evaluation of leprosy in New York City. JAMA 247 (1982) 3221-3226.
16. MAEDA, H. and JUJI, T. A new B-cell alloantigen, TB21, coded for in the HLA-D/DR region. Tissue Antigens 20 (1982) 327-334.
17. MEHRA, N. K., RAJALINGAM, R., MITRA, D. K., TANEJA, V. and GIPHART, M. J. Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians. Int. J. Lepr. 63 (1995) 241-248.
18. MIYANAGA, K., JUJI, T., MAEDA, H., NAKAJIMA, S. and KOBAYASHI, S. Tuberculoid leprosy and HLA in Japanese. Tissue Antigens 18 (1981) 331-334.
19. MOLKENTIN, J., GROSKI, J. and BAXTER-LOWE, L. A. Detection of 14 HLA-DQB1 alleles by oligotyping. Human Immunol. 31 (1991) 114-122.
20. NOMURA, N., OTA, M., TSUJI, K. and INOKO, H. HLA-DQB1 genotyping by modified PCR-RFLP method combined with alleles-specific primers. Tissue Antigens 38 ( 1991 ) 53-59.
21. ORITA, M., IWAHANA, H., KANAZAWA, H., HAYASHI, K. and SEKIYA, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 2766-2770.
22. OTA, M., SEKI, T., FUKUSHIMA, H., TSUJI, K. and INOKO, H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39 (1992) 187-202.
23. OTTENHOFF, T. H. M., GONZALEZ, N. M., DE VRIES, R. R. P., CONVIT, J. and VAN ROOD, J. J. Association of HLA specificity LB-E12(MB1,DC1,MT1) with lepromatous leprosy in a Venezuelan population. Tissue Antigens 24 (1984) 25-29.
24. POLLACK, M. S., CHING, C., PANDEY, J. and REICHERT, E. HLA antigen frequencies and HLA and Gm haplotype segregation in Filipino leprosy patients in Hawaii. Dis. Markers 3 (1985) 119-129.
25. RANI, R., FERNANDEZ-VINA, M. A., ZAHEER, S. A., BEENA, K. R. and STASTNY, P. Study of HLA class II alleles by PCR oligotyping in leprosy patients from North India. Tissue Antigens 42 (1993) 133-137.
26. RANI, R., ZAHEER, S. A. and MUKHERJEE, R. Do human leukocyte antigens have a role to play in differential manifestations of multibacillary leprosy: a study on multibacillary leprosy patients from North India. Tissue Antigens 40 (1992) 124-127.
27. RIDLEY, D. S. and JOPLING, W. H. Classification of leprosy according to immunity; a five-group system. Int. J. Lepr. 34 (1966) 255-273.
28. ROY, S., MCGUIRE, W., MASCIE TAYLOR, C. G., SAHA, B., HAZRA, S. K., HILL, A. V. and KWIATKOWSKI, D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J. Infect. Dis. 176 (1997) 530-532.
29. SCHAUF, V., RYAN, S., SCOLLARD, D., JONASSON, O., BROWN, A., NELSON, K., SMITH, T. and VITHAYASAI, V. Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand. Tissue Antigens 26 (1985) 243-247.
30. SERJEANSTON, S. W., VAIDYA, M. C., CHAN, S. H., JUJI, G. T., MEHRA, N. K., NAIK, S. and SASAZUKI, T. Leprosy. In: Proceedings of the Second Asia and Oceania Histocompatibility Workshop Conference. Simons, M. J., and Tait, B. D., eds. Toorank, Victoria, Australia: Immunopublishing, 1983, pp. 379-401.
31. SOEBONO, H., GIPHART, M. J., SCHREUDER, G. M. T., KLATSER, P. R. and DE VRIES, R. R. P. Associations between HLA-DRB1 alleles and leprosy in an Indonesian Population. Int. J. Lepr. 65 (1997) 190-196.
32. TODD, J. R., WEST, B. C. and MCDONALD, J. C. Human leukocyte antigen and leprosy: study in northern Louisiana and review. Rev. Infect. Dis. 12 (1990) 63-74.
33. VAN EDEN, W., DE VRIES, R. R. P., D'AMARO, J., SCHREUDER, I., LEIKER, D. L. and VAN ROOD, J. J. HLA-DR-associated genetic control of the type of leprosy in a population from Surinam. Hum. Immunol. 4 (1982) 343-350.
34. VAN EDEN, W., DE VRIES, R. R. P., MEHRA, N. K., VAIDYA, M. C., D'AMARO, J. and VAN ROOD, J. J. HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. J. Infect. Dis. 141 (1980) 693-701.
35. VAN EDEN, W., GONZALEZ, N. M., DE VRIES, R. R. P., CONVIT, J. and VAN ROOD, J. J. HLA-linked control of predisposition to lepromatous leprosy. J. Infect. Dis. 151 (1985) 9-14.
36. VAN EDEN, W., MEHRA, N. K., VAIDYA, M. C., D'AMARO, J., SCHREUDER, G. M. T. H. and VAN ROOD, J. J. HLA and sporadic tuberculoid leprosy: a population study in Maharashtra, India. Tissue Antigens 18 (1981) 189-194.
37. WHO EXPERT COMMITTEE ON LEPROSY. Sixth report. Geneva: World Health Organization, 1998. Tech. Rep. Ser. 768.
38. WHO STUDY GROUP. Chemotherapy of leprosy for control programmes. Geneva: World Health Organization, 1982. Tech. Rep. Ser. 675.